Cerity Partners LLC Biogen Inc. Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

A detailed history of Cerity Partners LLC transactions in Biogen Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 7,785 shares of BIIB stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,785

Previous 5,755 35.27%

Holding current value

$1.16 Million

Previous $1.33 Million 13.12%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$189.07 - $236.8 $383,812 - $480,704	2,030 Added 35.27%	7,785 $1.51 Million
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $120,218 - $149,370	-631 Reduced 9.88%	5,755 $1.33 Million
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $786,170 - $992,668	3,708 Added 138.46%	6,386 $1.38 Million
Q4 2023 Jan 26, 2024	BUY	$222.59 - $267.94 $80,132 - $96,458	360 Added 15.53%	2,678 $692,000
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $194,534 - $219,563	-768 Reduced 24.89%	2,318 $595,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $369,936 - $427,472	1,344 Added 77.15%	3,086 $879,000
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $58,239 - $66,361	-227 Reduced 11.53%	1,742 $484,000
Q4 2022 Feb 15, 2023	BUY	$252.44 - $306.72 $97,441 - $118,393	386 Added 24.38%	1,969 $545,000
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $15,964 - $22,013	82 Added 5.46%	1,583 $422,000
Q2 2022 Aug 10, 2022	BUY	$187.54 - $223.02 $281,497 - $334,753	1,501 New	1,501 $305,000
Q1 2022 Apr 25, 2022	SELL	$193.77 - $244.14 $166,642 - $209,960	-860 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $192,571 - $247,482	860 New	860 $208,000
Q1 2021 May 12, 2021	SELL	$242.95 - $284.63 $274,290 - $321,347	-1,129 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $371,873 - $559,761	-1,574 Reduced 58.23%	1,129 $277,000
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $18,533 - $21,399	-70 Reduced 2.52%	2,703 $767,000
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $96,738 - $128,113	374 Added 15.59%	2,773 $742,000
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $44,897 - $56,953	-167 Reduced 6.51%	2,399 $759,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $564,673 - $780,243	2,566 New	2,566 $761,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $329,373 - $363,063	-1,502 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $140,428 - $219,646	-648 Reduced 30.14%	1,502 $355,000
Q4 2018 Feb 06, 2019	BUY	$278.5 - $352.75 $75,752 - $95,948	272 Added 14.48%	2,150 $647,000
Q3 2018 Nov 15, 2018	SELL	$293.51 - $383.83 $19,078 - $24,948	-65 Reduced 3.35%	1,878 $664,000
Q2 2018 Aug 15, 2018	BUY	$257.52 - $306.91 $198,032 - $236,013	769 Added 65.5%	1,943 $564,000
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $305,392 - $431,926	1,174 New	1,174 $321,000
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $439,002 - $491,715	-1,427 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $401,201 - $470,467	1,427	1,427 $447,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account

Cerity Partners LLC Biogen Inc. Transaction History